Discover the detailed record of transactions filed by Chen Hongming. Director active across 1 companies, notably Kala Pharmaceuticals, Inc.. Aggregated, 6 disclosures have been published. Total volume traded: €105k. The latest transaction was disclosed on 26 October 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.